About Us

Management

Our founders are globally acknowledged scientists and drug development leaders whose vision is to make a difference in AML patient care.

Florent Gros

Chief Executive Officer and Founder

Read more

Stephan Oehen

Chief Operating Officer
and Founder

Read more

Philippe Lievre

Chief Business Officer
and Founder

Read more

Brice Suire

Chief Financial Officer and Founder

Read more

Supervisory Board

Our supervisory board is composed of venture capital leaders from leading international venture funds, also joined by Dr. Dhaval Patel, leader in S1Pr drug developments (Gilenya).

Manus Rogan

Chair
Read more

Dhaval Patel

Director
Read more

Marten Steen

Director
Read more

Henry Skinner

Director
Read more

Lionel Carnot

Director
Read more

Advisory Board

Christoph Bucher

Head of Clinical Advisory Board and Founder

Read more

Simone Seiter

Head of Commercial and Scientific Advisory Board and Founder

Read more

Investors Funds